Compounds > aluminum
Page last updated: 2024-08-26

aluminum and Malaria, Falciparum

aluminum has been researched along with Malaria, Falciparum in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arisue, N; Bougouma, EC; Coulibaly, SA; Cousens, S; D'Alessio, F; Diarra, A; Horii, T; Houard, S; Leroy, O; Nebie, I; Ouédraogo, A; Ouedraogo, AZ; Palacpac, NMQ; Sirima, SB; Soulama, I; Tiono, AB; Tougan, T; Yagi, M; Yaro, JB1
Aebig, J; Barnafo, E; Butler, B; Dai, W; Duffy, PE; Jones, D; Lambert, L; McClellan, H; Narum, DL; Rausch, K; Wu, Y; Zhu, D1

Trials

1 trial(s) available for aluminum and Malaria, Falciparum

ArticleYear
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
    Frontiers in immunology, 2022, Volume: 13

    Topics: Aluminum; Antigens, Protozoan; Child; Child, Preschool; Humans; Malaria Vaccines; Malaria, Falciparum; Plasmodium falciparum

2022

Other Studies

1 other study(ies) available for aluminum and Malaria, Falciparum

ArticleYear
Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®.
    Vaccine, 2017, 05-31, Volume: 35, Issue:24

    Topics: Adjuvants, Immunologic; Aluminum; Aluminum Hydroxide; Animals; Clinical Trials, Phase I as Topic; Drug Compounding; Malaria Vaccines; Malaria, Falciparum; Mice; Plasmodium falciparum; Protozoan Proteins; Pseudomonas aeruginosa; Recombinant Proteins; Temperature; Vaccine Potency

2017